Claudia Mitchell
Angel Investor
Claudia Mitchell is a startup investor. Claudia Mitchell is the former CEO and co-founder of Universal Cells Inc. She previously co-founded Halo-Bio RNAi Therapeutics, a biotech start-up company developing new RNAi molecules, and served as its Chief Scientific Officer from 2008 to 2011. Besides being a biotech entrepreneur, Claudia has also held positions in the non-profit sector and inacademia; she worked as the Program Director at the LGMD2I Research Fund, a family non-profit foundation, and has held a tenured Academic research position at the French National Institute of Medical Research (INSERM).She received a Masters in Molecular Virology from the Federal University of Rio de Janeiro, Brazil, a Ph.D. in Molecular Biology from the University of Paris and an Executive MBA from the Ecole des Ponts Business School, Paris, France.
Last updated:
For AI agents: llms.txt
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
How do I contact Claudia Mitchell?
Public channels for Claudia Mitchell include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
